Altair Engineering Inc.
—- Market cap
- —
- Debt
- +$237.99M
- Cash
- −$561.90M
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: ALTR stock price vs OPK: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at OPK's multiple
Needs OPK P/E.
Implied fair value · at ALTR's multiple
Needs EPS (TTM) is negative, ALTR P/E.
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: ALTR FY 2024 (ended Dec 31, 2024) · OPK FY 2025 (ended Dec 31, 2025). Fiscal years are not aligned.
Trendline
Seven fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 64% equity / 36% debt · EV / Revenue 2.55x
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
ALTAIR ENGINEERING INC. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
OPKO Health, Inc. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.28x
0.54x
Net debt / EBITDA
Leverage against operating earnings
-3.81x
-3.03x
Cash and equivalents
Liquid reserves on the balance sheet
$561.90M
$364.41M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
ANSYS INC
ALTR vs ANSS
PTC INC.
ALTR vs PTC
BENTLEY SYSTEMS INC
ALTR vs BSY
Autodesk, Inc.
ALTR vs ADSK
ORACLE CORP
ALTR vs ORCL
AMARIN CORP PLC\UK
ALTR vs AMRN
Sarepta Therapeutics, Inc.
ALTR vs SRPT
Amphastar Pharmaceuticals, Inc.
ALTR vs AMPH
SUPERNUS PHARMACEUTICALS, INC.
ALTR vs SUPN
Harmony Biosciences Holdings, Inc.
ALTR vs HRMY
$237.99M
$687.93M
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.